London, UK, 7 January 2015: MRC Technology has signed an agreement with Diabetes UK to manage its intellectual property (IP). The partnership will enable Diabetes UK to benefit from MRC Technology’s expertise in IP management, translation and drug discovery, allowing the charity to maximise benefits to patients and return on investment from its research portfolio.
Under the agreement, MRC Technology will review and monitor the overall research portfolio of Diabetes UK, advising on strategies that best realise the commercial potential of research projects. MRC Technology will negotiate on behalf of Diabetes UK with grant holders and Technology Transfer Officers, and will assist in the protection, management and exploitation of associated IP. It will also negotiate robust revenue share agreements to ensure the value of research funding provided by Diabetes UK is fully reflected.
Mike Johnson, Director of Corporate Partnerships at MRC Technology said: “Being a charity ourselves, we strive to improve human health through life science innovations and are therefore ideally placed to support Diabetes UK in improving care and treatments for diabetes patients. MRC Technology has worked with eight of the UK’s leading charities to maximise benefits to patients and return on research investment. Our growing relationship with charities means we are increasingly offering consortia opportunities and research strategy development.”
Alasdair Rankin, Director of Research at Diabetes UK, said: “Diabetes UK funds research to make life better for people with all forms of diabetes. We work to improve care for people living with diabetes, to prevent diabetes in people who don’t yet have it and ultimately to cure the condition in those who have it today or will develop it in the future. Diabetes UK research has led to vital developments including modern insulin pen devices, blood glucose testing and the UK retinal screening programme. Our agreement with MRC Technology will help us ensure we have the expertise to bring the benefits of today’s research to people with diabetes as fast as possible.”
-ends-
Further information
Liezel Tipper, PR and Communications Manager, MRC Technology.
Email: ltipper@tech.mrc.ac.uk
Phone +44(0) 20 7391 2772
About MRC Technology
MRC Technology (www.mrctechnology.org) is an independent life science medical research charity, offering professional services to organisations within the academic, charity, biotechnology and pharmaceutical sectors globally. Services include IP management and research and development for diagnostics, small molecules and therapeutic antibodies. MRC Technology bridges the gap between basic medical research and commercialisation, helping early discoveries progress to clinical application.
Please note MRC Technology has been independent from the UK’s Medical Research Council (MRC) since 2000.
About Diabetes UK
1. Diabetes UK is the leading UK charity that cares for, connects with and campaigns on behalf of all people affected by and at risk of diabetes. For more information on all aspects of diabetes and access to Diabetes UK activities and services, visit www.diabetes.org.uk
2. In the UK, there are around 3.8 million people who have diabetes. There are 3.2 million people living with Type 1 and Type 2 diabetes, and around 630,000 more who have Type 2 diabetes but don’t know they have it because they haven’t been diagnosed. As many as 11.5 million people are at high risk of developing Type 2 diabetes and if current trends continue, an estimated 5 million people will have diabetes by 2025.
3. Diabetes is a condition where there is too much glucose in the blood because the body cannot use it properly. If not managed well, both Type 1 and Type 2 diabetes can lead to devastating complications. Diabetes is the leading cause of blindness in people of working age in the UK and is a major cause of lower limb amputation, kidney failure and stroke.
4. People with Type 1 diabetes cannot produce insulin. About 10 per cent of people with diabetes have Type 1. No one knows exactly what causes it, but it’s not to do with being overweight and it isn’t currently preventable. It usually affects children or young adults, starting suddenly and getting worse quickly. Type 1 diabetes is treated by daily insulin doses - taken either by injections or via an insulin pump – a healthy diet and regular physical activity.
5. People with Type 2 diabetes don’t produce enough insulin or the insulin they produce doesn’t work properly (known as insulin resistance). 85 to 90 per cent of people with diabetes have Type 2. They might get Type 2 diabetes because of their family history, age and ethnic background puts them at increased risk. They are also more likely to get Type 2 diabetes if they are overweight. It starts gradually, usually later in life, and it can be years before they realise they have it. Type 2 diabetes is treated with a healthy diet and increased physical activity. In addition, tablets and/or insulin can be required.
6. For more information on reporting on diabetes, download our journalists’ guide: www.diabetes.org.uk/journalists-guide
Liezel Tipper
PR & Communications Manager
MRC Technology
Lynton House
7-12 Tavistock Square
LONDON WC1H 9LT
Direct: +44 (0)20 7391 2772
Mobile: +44 (0)7718 118697
ltipper@tech.mrc.ac.uk
www.mrctechnology.org
Twitter @MRCTechnology
Help employers find you! Check out all the jobs and post your resume.
Under the agreement, MRC Technology will review and monitor the overall research portfolio of Diabetes UK, advising on strategies that best realise the commercial potential of research projects. MRC Technology will negotiate on behalf of Diabetes UK with grant holders and Technology Transfer Officers, and will assist in the protection, management and exploitation of associated IP. It will also negotiate robust revenue share agreements to ensure the value of research funding provided by Diabetes UK is fully reflected.
Mike Johnson, Director of Corporate Partnerships at MRC Technology said: “Being a charity ourselves, we strive to improve human health through life science innovations and are therefore ideally placed to support Diabetes UK in improving care and treatments for diabetes patients. MRC Technology has worked with eight of the UK’s leading charities to maximise benefits to patients and return on research investment. Our growing relationship with charities means we are increasingly offering consortia opportunities and research strategy development.”
Alasdair Rankin, Director of Research at Diabetes UK, said: “Diabetes UK funds research to make life better for people with all forms of diabetes. We work to improve care for people living with diabetes, to prevent diabetes in people who don’t yet have it and ultimately to cure the condition in those who have it today or will develop it in the future. Diabetes UK research has led to vital developments including modern insulin pen devices, blood glucose testing and the UK retinal screening programme. Our agreement with MRC Technology will help us ensure we have the expertise to bring the benefits of today’s research to people with diabetes as fast as possible.”
-ends-
Further information
Liezel Tipper, PR and Communications Manager, MRC Technology.
Email: ltipper@tech.mrc.ac.uk
Phone +44(0) 20 7391 2772
About MRC Technology
MRC Technology (www.mrctechnology.org) is an independent life science medical research charity, offering professional services to organisations within the academic, charity, biotechnology and pharmaceutical sectors globally. Services include IP management and research and development for diagnostics, small molecules and therapeutic antibodies. MRC Technology bridges the gap between basic medical research and commercialisation, helping early discoveries progress to clinical application.
Please note MRC Technology has been independent from the UK’s Medical Research Council (MRC) since 2000.
About Diabetes UK
1. Diabetes UK is the leading UK charity that cares for, connects with and campaigns on behalf of all people affected by and at risk of diabetes. For more information on all aspects of diabetes and access to Diabetes UK activities and services, visit www.diabetes.org.uk
2. In the UK, there are around 3.8 million people who have diabetes. There are 3.2 million people living with Type 1 and Type 2 diabetes, and around 630,000 more who have Type 2 diabetes but don’t know they have it because they haven’t been diagnosed. As many as 11.5 million people are at high risk of developing Type 2 diabetes and if current trends continue, an estimated 5 million people will have diabetes by 2025.
3. Diabetes is a condition where there is too much glucose in the blood because the body cannot use it properly. If not managed well, both Type 1 and Type 2 diabetes can lead to devastating complications. Diabetes is the leading cause of blindness in people of working age in the UK and is a major cause of lower limb amputation, kidney failure and stroke.
4. People with Type 1 diabetes cannot produce insulin. About 10 per cent of people with diabetes have Type 1. No one knows exactly what causes it, but it’s not to do with being overweight and it isn’t currently preventable. It usually affects children or young adults, starting suddenly and getting worse quickly. Type 1 diabetes is treated by daily insulin doses - taken either by injections or via an insulin pump – a healthy diet and regular physical activity.
5. People with Type 2 diabetes don’t produce enough insulin or the insulin they produce doesn’t work properly (known as insulin resistance). 85 to 90 per cent of people with diabetes have Type 2. They might get Type 2 diabetes because of their family history, age and ethnic background puts them at increased risk. They are also more likely to get Type 2 diabetes if they are overweight. It starts gradually, usually later in life, and it can be years before they realise they have it. Type 2 diabetes is treated with a healthy diet and increased physical activity. In addition, tablets and/or insulin can be required.
6. For more information on reporting on diabetes, download our journalists’ guide: www.diabetes.org.uk/journalists-guide
Liezel Tipper
PR & Communications Manager
MRC Technology
Lynton House
7-12 Tavistock Square
LONDON WC1H 9LT
Direct: +44 (0)20 7391 2772
Mobile: +44 (0)7718 118697
ltipper@tech.mrc.ac.uk
www.mrctechnology.org
Twitter @MRCTechnology
Help employers find you! Check out all the jobs and post your resume.
